Manufacturer record
ANG Lifesciences India Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
32 batches manufactured by ANG Lifesciences India Ltd (Himachal Pradesh) were declared Not of Standard Quality between July 2019 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AA013026, Pantoprazole for Injection BP 40 mg (exp May 2025). CDL, Kolkata (CDSCO lab) found it not of standard quality: Clarity and Colour of Solution. Listed in the May 2025 alert.
Records by type
32 records linked to ANG Lifesciences India Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole for Injection BP 40 mg | Batch AA013026Mfg Jun 2023 · Exp May 2025 | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Pantoprazole for Injection BP 40 mg | Batch AA013043Mfg Aug 2023 · Exp Jul 2025 | Clarity and colour of solutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Pantoprazole for Injection BP 40 mg | Batch AA013047Mfg Sep 2023 · Exp Aug 2025 | Clarity and Colour of SolutionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Amoxycillin & Potassium Clavulanate Injection IP. | Batch AB193049AMfg May 2023 · Exp Apr 2025 | Assay (Content of Clavulanic Acid)Assay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| Piperacillin and Tazobactam Injection IP (CASIDTAZ P Injection) | Batch AB154006BMfg Jun 2024 · Exp May 2026 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Cefoperazone and Sulbactam for Injection (KEFZONE-S INJECTION) | Batch AB234007CMfg Jun 2024 · Exp May 2026 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Enalapril Maelate Tablets IP 5 mg | Batch T013002Mfg Jun 2023 · Exp May 2025 | Assay of Enalapril MaleateAssay | RDTL ChandigarhCDSCO lab | Mar 2024 |
| DICLOFENAC SODIUM INJECTION I.P. 75mg/3ml | Batch I213109Mfg Jul 2023 · Exp Jun 2025 | DescriptionDescription | RDTL GuwahatiState lab | Feb 2024 |
| Folic Acid Tablets IP 5 mg | Batch T112005Mfg May 2022 · Exp Apr 2024 | Description as the tablets are brittle & shows mottled appearanceDescription | CDTL MumbaiCDSCO lab | Jan 2024 |
| Diclofenac Sodium Injection IP | Batch I213108Mfg Jul 2023 · Exp Jun 2025 | Particulate matter and DescriptionDescription | RDTL GuwahatiState lab | Jan 2024 |
| Ciprofloxacin Tablets I.P. 500 mg | Batch T032022Mfg Nov 2022 · Exp Oct 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| CIPROFLOXACIN TABLETS I.P. 500 mg. | Batch T032023Mfg Nov 2022 · Exp Oct 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| Ascorbic Acid Tablets I.P. 500 mg. | Batch T392017Mfg Mar 2022 · Exp Feb 2024 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2023 |
| Telmisartan Tablets I.P. 40mg. | Batch T101004Mfg Sep 2021 · Exp Aug 2023 | DescriptionDescription | RDTL GuwahatiState lab | Jul 2023 |
| Folic Acid Tablets IP 5mg | Batch T112005Mfg May 2022 · Exp Apr 2024 | Description & Hydrolysis ProductsDescription | CDL KolkataCDSCO lab | Jul 2023 |
| Glimepiride Tablets IP 2 mg | Batch T192009Mfg May 2022 · Exp Apr 2024 | Dissolution of GlimepirideDissolution | RDTL ChandigarhCDSCO lab | May 2023 |
| Telmisartan Tablets IP 40 mg | Batch T101004Mfg Sep 2021 · Exp Aug 2023 | Dissolution & DescriptionDissolution | RDTL GuwahatiState lab | Mar 2023 |
| Ascorbic Acid Tablets IP 500mg | Batch T392012Mfg Jan 2022 · Exp Dec 2023 | DescriptionDescription | RDTL GuwahatiState lab | Mar 2023 |
| Telmisartan Tablets IP 40 mg | Batch T101006Mfg Sep 2021 · Exp Aug 2023 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| Paracetamol Tablets IP 650mg | Batch T120214Mfg Apr 2022 · Exp Mar 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2022 |
| ONDASETRON TABLETS IP 4 mg | Batch T351001Mfg Aug 2021 · Exp Jul 2023 | Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Oct 2022 |
| Paracetamol Tablets IP 650 mg | Batch T120210Mfg Feb 2022 · Exp Jan 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Ascorbic Acid Tablets IP 500 mg | Batch T392006Mfg Jan 2022 · Exp Dec 2023 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Paracetamol Tablets I.P. 650 mg | Batch BTPM110Mfg Sep 2021 · Exp Aug 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2022 |
| Paracetamol Tablets IP 650 mg | Batch BTPT-107Mfg Jul 2021 · Exp Jun 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| ENALAPRIL MALEATE TABLETS I.P. 5mg | Batch T012001Mfg Feb 2022 · Exp Jan 2024 | Description,Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Jul 2022 |
| Domperidone Tablets I.P. 10 mg | Batch T141001Mfg Jul 2021 · Exp Jun 2023 | AssayAssay | CDL KolkataCDSCO lab | Feb 2022 |
| Pantoprazole for Injection B.P. 40 mg | Batch AA011068Mfg Apr 2021 · Exp Mar 2023 | SterilitySterility | CDL KolkataCDSCO lab | Jan 2022 |
| (PANTOPRAZOLE FOR INJECTION BP 40 MG) | Batch AA010102Mfg May 2020 · Exp Apr 2022 | Particulate matterParticulate matter | RDTL ChandigarhState lab | Dec 2021 |
| PANTOPRAZOLE SODIUM TABLETS IP 40 MG | Batch ATPP-2011Mfg Jun 2020 · Exp May 2022 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2020 |
| Cefotaxime Injection IP | Batch AB029001AMfg Feb 2019 · Exp Jan 2021 | Related SubstancesRelated substances | RDTL ChandigarhState lab | Apr 2020 |
| (Cefotaxime Injection IP) | Batch B028004AMfg Jul 2018 · Exp Jun 2020 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Jul 2019 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP | 825D167 | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | May 2026 |
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.